Date & Location
Saturday, March 2, 2013
7 am - 2:30 pm
Detroit Marriott Troy
200 W. Big Beaver Rd.
Troy, MI 48084
AMA/ACCME WSU SOM CME 2012-2013
Accreditation Statement (Live Activity) For Jointly Sponsored Activities
“This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Wayne State University School of Medicine and Michigan Society of Hematology Oncology. The Wayne State University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Wayne State University School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physician’s should only claim credit commensurate with the extent of their participation in the activity.”
This program is geared towards physicians, fellows, residents, pathologists, physician assistants, and nurse practitioners in the field of hematology/oncology.
Upon completion of this program, the participant will:
- Understand diagnostic and therapeutic strategies used in the multimodality treatment of patients with breast cancer.
- Understand the use of new agents, both cytotoxic and biologic, and their uses in breast cancers.
- Understand the latest research findings in all areas of breast cancer and how the updated research could impact future decision making in the diagnosis and treatment of these cancers.
- Physicians please bring any cases you would like to discuss.
Pre-registration is encouraged since space is limited. Registration deadline is February 22, 2013.
- $125 for physicians
- $50 for nurses and physician extenders.
- Free to all fellows, residents and students.
Checks should be made out to FMRE (Fund for Medical Research Education).
Pre-registration is closed. You can register on-site the day of the event.
(Download the brochure)
7:00 – 8:00 - Registration
8:00 – 8:10 - Introduction, Michael Simon, M.D., MPH
8:10 – 8:30 - Breast Imaging: New Technology, Sharon Helmer, M.D.
8:30 – 9:00 - Surgical Management in the Setting of Neo-Adjuvant Chemo, Keiva Bland, M.D.
9:00 – 9:45 - Health Policy & the ACA: Pulling back the curtain on the workforce for clinical oncology, Claude Desjardins, M.D.
9:45 – 10:00 - BREAK
10:00 – 10:20 - Radiation Oncology: Hypo-fractionation for Breast Cancer, Neha Amin, M.D.
10:20 – 11:05 - Using the Pre-Surgical Setting as a Model for New Drug Development for Breast Cancer, Vered Stearns, M.D.
11:05 – 11:20 - BREAK
11:20 –11:40 - Update in Neo-adjuvant and Adjuvant Treatment of Breast Cancer, Sayeh Lavasani, M.D.
11:40 – 12:25 - Radiation Oncology: Management of the Axilla, Christine Fisher, M.D.
12:25 – 1:35 - LUNCH/CASES Lawrence Flaherty, M.D.
1:35 – 1:55 - Palliative Care in Management of Metastatic Breast Cancer, Michael Stellini, M.D.
1:55 – 2:30 Update in Treatment of Metastatic Breast Cancer, Jeffrey Smerage, M.D.
For more information on this event please contact LaTanya Johnson at (313) 576-8751 or firstname.lastname@example.org, or view the event brochure.